116 related articles for article (PubMed ID: 27459971)
1. Elevated STC‑1 augments the invasiveness of triple‑negative breast cancer cells through activation of the JNK/c‑Jun signaling pathway.
Han J; Jeon M; Shin I; Kim S
Oncol Rep; 2016 Sep; 36(3):1764-71. PubMed ID: 27459971
[TBL] [Abstract][Full Text] [Related]
2. STC-1 expression is upregulated through an Akt/NF-κB-dependent pathway in triple-negative breast cancer cells.
Jeon M; Han J; Nam SJ; Lee JE; Kim S
Oncol Rep; 2016 Sep; 36(3):1717-22. PubMed ID: 27461417
[TBL] [Abstract][Full Text] [Related]
3. Elevated IL-1β expression induces invasiveness of triple negative breast cancer cells and is suppressed by zerumbone.
Jeon M; Han J; Nam SJ; Lee JE; Kim S
Chem Biol Interact; 2016 Oct; 258():126-33. PubMed ID: 27567548
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer.
Zhao C; Qiao Y; Jonsson P; Wang J; Xu L; Rouhi P; Sinha I; Cao Y; Williams C; Dahlman-Wright K
Cancer Res; 2014 Jul; 74(14):3983-94. PubMed ID: 24830720
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer.
Chung SY; Jung YY; Park IA; Kim H; Chung YR; Kim JY; Park SY; Im SA; Lee KH; Moon HG; Noh DY; Han W; Lee C; Kim TY; Ryu HS
Clin Exp Metastasis; 2016 Feb; 33(2):179-85. PubMed ID: 26585892
[TBL] [Abstract][Full Text] [Related]
6. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
7. MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Tumour Biol; 2016 Apr; 37(4):4991-9. PubMed ID: 26537583
[TBL] [Abstract][Full Text] [Related]
8. Depletion of SENP1 suppresses the proliferation and invasion of triple-negative breast cancer cells.
Wang Z; Jin J; Zhang J; Wang L; Cao J
Oncol Rep; 2016 Oct; 36(4):2071-8. PubMed ID: 27573572
[TBL] [Abstract][Full Text] [Related]
9. Expression of NY-ESO-1 in Triple-Negative Breast Cancer Is Associated with Tumor-Infiltrating Lymphocytes and a Good Prognosis.
Lee HJ; Kim JY; Song IH; Park IA; Yu JH; Gong G
Oncology; 2015; 89(6):337-44. PubMed ID: 26413775
[TBL] [Abstract][Full Text] [Related]
10. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR
Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605
[TBL] [Abstract][Full Text] [Related]
11. ART3 regulates triple-negative breast cancer cell function via activation of Akt and ERK pathways.
Tan L; Song X; Sun X; Wang N; Qu Y; Sun Z
Oncotarget; 2016 Jul; 7(29):46589-46602. PubMed ID: 27374177
[TBL] [Abstract][Full Text] [Related]
12. S100A14 is a novel independent prognostic biomarker in the triple-negative breast cancer subtype.
Ehmsen S; Hansen LT; Bak M; Brasch-Andersen C; Ditzel HJ; Leth-Larsen R
Int J Cancer; 2015 Nov; 137(9):2093-103. PubMed ID: 25912829
[TBL] [Abstract][Full Text] [Related]
13. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
14. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells.
Kim S; Lee J; Jeon M; Nam SJ; Lee JE
Cytokine; 2015 Sep; 75(1):151-8. PubMed ID: 26088755
[TBL] [Abstract][Full Text] [Related]
15. New insight on the biological role of p53 protein as a tumor suppressor: re-evaluation of its clinical significance in triple-negative breast cancer.
Jin MS; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Han W; Noh DY; Ryu HS
Tumour Biol; 2016 Aug; 37(8):11017-24. PubMed ID: 26894602
[TBL] [Abstract][Full Text] [Related]
16. Celastrol attenuates the inflammatory response by inhibiting IL‑1β expression in triple‑negative breast cancer cells.
You D; Jeong Y; Yoon SY; A Kim S; Kim SW; Nam SJ; Lee JE; Kim S
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846813
[TBL] [Abstract][Full Text] [Related]
17. E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer.
Chen HA; Chang YW; Tseng CF; Chiu CF; Hong CC; Wang W; Wang MY; Hsiao M; Ma JT; Chen CH; Jiang SS; Wu CH; Hung MC; Huang MT; Su JL
Ann Surg Oncol; 2015 Mar; 22(3):889-98. PubMed ID: 25212833
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
[TBL] [Abstract][Full Text] [Related]
19. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
20. CLDN6 enhances chemoresistance to ADM via AF-6/ERKs pathway in TNBC cell line MDAMB231.
Yang M; Li Y; Ruan Y; Lu Y; Lin D; Xie Y; Dong B; Dang Q; Quan C
Mol Cell Biochem; 2018 Jun; 443(1-2):169-180. PubMed ID: 29159771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]